Skip to main content

IRS outlines priorities for 2021

The Internal Revenue Service’s Tax Exempt and Government Entities division issued a “Program Letter” that outlines its priorities for the 2021 fiscal year. The letter supplements the “Fiscal Year 2020 Compliance Program Letter,” which outlines the IRS’ examination initiatives.

While the letters list several initiatives, among particular interest with respect to retirement plans are the following:

Internal Revenue Code Section 403(b)/457 Plans: Examine 403(b) plans for universal availability, excessive contributions and proper use of catch-up contributions under IRC Section 414(v); and examine 457(b) plans for excessive contributions and proper use of the special three-year catch-up contribution rule. This strategy began in FY 2020.

Small exempt organizations that sponsor retirement plans: Review retirement plans of small exempt organizations to determine whether the plan investments are properly administered, whether there are any party-in-interest transactions in the plan trust and whether any participant loans violate IRC Section 72(p).

Worker classification:
  • Tax-exempt entities: Review worker classification to ensure taxpayers aren’t reducing their tax burden by incorrectly treating workers as independent contractors instead of employees.
  • 401(k) focus: Review retirement plans of employers that were determined to have misclassified employees as independent contractors, to determine if coverage requirements of the IRC are satisfied.
Retirement plan participant loans: Ensure that participant loans comply with IRC Section 72(p) rules on maximum loan balances and IRC Section 72(t) re-payment rules for early distributions before age 59½ and verify whether participant loans of retirement plans that hold a high percentage of participant loans to total assets of the trust are being repaid timely if the loan balance remains consistent or increases for more than one year.

Required minimum distributions in large defined benefit plans: Ensure retirement plan sponsors comply with IRC Section 401(a)(9) to begin distribution of benefits by the required beginning date.

The IRS will utilize the examination process to check these areas. Once a plan is selected for audit, if any error found is deemed “significant,” generally the only recourse is to enter into an Audit Closing Agreement Program with the IRS. The Audit CAP not only requires the plan sponsor to make the correction but also imposes a sanction payable to the agency. While the plan sponsor may negotiate the amount of the sanction, the best recourse is to be proactive, ensure your plan is in compliance with all rules and regulations and make any corrections if needed ahead of any examination by the IRS.

If you have any questions or would like to begin talking to a retirement plan advisor, please get in touch by email or by calling (800) 388-1963.

Popular posts from this blog

SECURE 2.0 Discussion Series: Session Two

The retirement industry has been buzzing since the SECURE 2.0 Act was signed into law last December. This new, comprehensive legislation has sparked a lot of discussion. As with any major reform, it will take time for the industry to fully adapt and understand all its implications. Following our April 11 webinar on the first three months of the industry’s response, our team reconvened to discuss some of what we have heard from our client and vendor partners and to respond to some of the great questions we heard from attendees. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. The Discussion SB – Throughout the webinar, I wanted to stress two things: 1) confusion about where to start and what is expected from plan sponsors is normal; and 2) even more than three months in, this is a developing situation and people should expect changes as time goes on. With those in mind, engagement through

SECURE 2.0 Discussion Series: Session One

SECURE 2.0 provisions: What we know and what’s still up in the air The SECURE 2.0 Act, signed into law in late December 2022, has factored heavily in retirement industry discourse since the final legislation was published. As with any legislation of this depth and breadth, there’s a lot to digest and the industry takes time to adjust. Our team of experienced advisors recently met to discuss some of the more nuanced provisions of the legislation, such as changes to Roth contributions, and what they could mean for plan sponsors. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. Highlights of our panel’s conversation below should serve to help guide plan sponsor thinking. On Roth employer contributions NB – In addition to deferring pre-tax or Roth, plan sponsors can now allow employer contributions to be classified as Roth, is that right? VB – Correct. This is immediately available to plan s

What you should know about biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers for the foreseeable future. As a result, many employers are considering strategies to manage these costs, including rising prescription drug costs. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs. This article explores biosimilar drugs and ways employers can promote or manage their use. What are biosimilars? The European Medicines Agency defines a biosimilar as “a biological medicine highly similar to another already approved biological medicine.” It is produced from living organisms — humans, animals or microorganisms, meaning they aren’t created from synthesized chemicals. They are also